Tamara Hershey
Overview
Explore the profile of Tamara Hershey including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
140
Citations
3025
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kafashan M, Lebovitz L, Greenspan R, Zhao S, Kim T, Husain M, et al.
BMJ Open
. 2025 Mar;
15(3):e098859.
PMID: 40054874
Introduction: Electroconvulsive therapy (ECT) is a highly effective treatment for refractory depression, but it may also cause cognitive side effects. Despite decades of use, the mechanisms by which ECT exerts...
2.
Ray M, Fleming J, Aschenbrenner A, Hassenstab J, Redwine B, Burns C, et al.
JMIR Form Res
. 2025 Feb;
9:e60275.
PMID: 39935012
Background: Studies have shown a relationship between worse glycemic control and lower cognitive scores in youths with type 1 diabetes (T1D). However, most studies assess long-term glucose control (eg, years-decades)...
3.
Che T, Kim S, Greene D, Heywood A, Ding J, Hershey T, et al.
CNS Spectr
. 2024 Nov;
29(6):652-664.
PMID: 39604269
Objective: This study examined children at the onset of tic disorder (tics for less than 9 months: NT group), a population on which little research exists. Here, we investigate relationships...
4.
Clinical Trials for Wolfram Syndrome Neurodegeneration: Novel Design, Endpoints, and Analysis Models
Wang G, Li Z, Chen L, Lugar H, Hershey T
medRxiv
. 2024 Sep;
PMID: 39314971
Objective: Wolfram syndrome, an ultra-rare condition, currently lacks effective treatment options. The rarity of this disease presents significant challenges in conducting clinical trials, particularly in achieving sufficient statistical power (e.g.,...
5.
Blazey T, Lee J, Snyder A, Goyal M, Hershey T, Arbelaez A, et al.
bioRxiv
. 2024 Sep;
PMID: 39314314
Multiple studies have shown that hyperglycemia increases the cerebral metabolic rate of glucose (CMRglc) in subcortical white matter. This observation remains unexplained. Using positron emission tomography (PET) and euinsulinaemic glucose...
6.
7.
Norton S, Gorelik A, Paul S, Johnson E, Baranger D, Siudzinski J, et al.
medRxiv
. 2024 Sep;
PMID: 39252928
Background: C-reactive protein (CRP) is a moderately heritable marker of systemic inflammation that is associated with adverse physical and mental health outcomes. Identifying factors associated with genetic liability to elevated...
8.
Mazzoni P, Ushe M, Younce J, Norris S, Hershey T, Karimi M, et al.
J Neurophysiol
. 2024 Jul;
132(3):870-878.
PMID: 38985938
Bradykinesia is a term describing several manifestations of movement disruption caused by Parkinson's disease (PD), including movement slowing, amplitude reduction, and gradual decrease of speed and amplitude over multiple repetitions...
9.
Li Z, Ray M, Gu Y, Barch D, Hershey T
JAMA Pediatr
. 2024 Jun;
178(8):830-833.
PMID: 38829657
No abstract available.
10.
Siddiqi S, Klingbeil J, Webler R, Kratter I, Blumberger D, Fox M, et al.
Res Sq
. 2024 Apr;
PMID: 38659844
Transcranial magnetic stimulation (TMS) and deep brain stimulation (DBS) can treat some neuropsychiatric disorders, but there is no consensus approach for identifying new targets. We localized causal circuit-based targets for...